Beta-Blockers and Cancer: Where Are We?
Cancer is one of the leading causes of death worldwide. After diagnosis, cancer treatment may involve radiotherapy, chemotherapy, and surgery. Several of the approaches used to treat cancer also attack normal cells and, thus, there is the need for more effective treatments that decrease the toxicity...
Saved in:
Main Authors: | Rita Peixoto (Author), Maria de Lourdes Pereira (Author), Miguel Oliveira (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Where we are, where we are going
by: Teresa Bermejo-Vicedo, et al.
Published: (2020) -
Cancer care and the role of psychosocial oncology: Where are we and where are we going?
by: Barry D Bultz
Published: (2016) -
Metastatic Pancreatic Cancer: Where Are We?
by: Abraham Hernández-Blanquisett, et al.
Published: (2024) -
Where are we now and where are we headed?
by: Ewan A. Langan
Published: (2023) -
Transdermal Patches for Delivery of Beta-Blockers
by: Rohaľová S., et al.
Published: (2021)